Search hospitals > Idaho > Nampa
Saint Luke's Cancer Institute - Nampa
Claim this profileNampa, Idaho 83686
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Adenocarcinoma
Conducts research for Breast Cancer
Conducts research for Recurrence
248 reported clinical trials
6 medical researchers
Summary
Saint Luke's Cancer Institute - Nampa is a medical facility located in Nampa, Idaho. This center is recognized for care of Cancer, Lung Cancer, Adenocarcinoma, Breast Cancer, Recurrence and other specialties. Saint Luke's Cancer Institute - Nampa is involved with conducting 248 clinical trials across 442 conditions. There are 6 research doctors associated with this hospital, such as Alison K. Conlin, Charles W. Drescher, Nitya Alluri, and Krishna C. Alluri.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Alison K. ConlinProvidence Portland Medical Center4 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
99 reported clinical trials
175 drugs studied
Charles W. DrescherProvidence Portland Medical Center1 year of reported clinical research
Expert in Cancer
Studies Tumors
44 reported clinical trials
85 drugs studied
Nitya AlluriProvidence Portland Medical Center1 year of reported clinical research
Expert in Cancer
Studies Recurrence
28 reported clinical trials
79 drugs studied
Krishna C. AlluriProvidence Portland Medical Center4 years of reported clinical research
Expert in Cancer
Studies Adenocarcinoma
26 reported clinical trials
63 drugs studied
Clinical Trials running at Saint Luke's Cancer Institute - Nampa
Breast Cancer
Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Colorectal Cancer
Gastric Cancer
Gallbladder Cancer
Pancreatic Cancer
Squamous Cell Carcinoma
Multiple Myeloma
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This study is evaluating whether a drug used to treat high blood pressure and heart failure may help prevent heart damage in patients with breast cancer.
Recruiting2 awards Phase 323 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Saint Luke's Cancer Institute - Nampa?
Saint Luke's Cancer Institute - Nampa is a medical facility located in Nampa, Idaho. This center is recognized for care of Cancer, Lung Cancer, Adenocarcinoma, Breast Cancer, Recurrence and other specialties. Saint Luke's Cancer Institute - Nampa is involved with conducting 248 clinical trials across 442 conditions. There are 6 research doctors associated with this hospital, such as Alison K. Conlin, Charles W. Drescher, Nitya Alluri, and Krishna C. Alluri.